[Federal Register Volume 76, Number 14 (Friday, January 21, 2011)]
[Notices]
[Pages 3916-3917]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-1251]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
USC, as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable materials, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; NIDA B/START R03 Small Grant Review.
Date: February 9, 2011.
Time: 9 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852 (Virtual Meeting).
Contact Person: Gerald L. McLaughlin, PhD, Scientific Review
Administrator, Office of Extramural Affairs, National Institute on
Drug Abuse, NIH, DHHS, Room 4238, MSC 9550, 6001 Executive Blvd.,
Bethesda, MD
[[Page 3917]]
20892-9550, 301-402-6626, [email protected].
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; Seek, Test, Treat, and Retain: Addressing HIV Among
Vulnerable Populations (R01).
Date: February 9, 2011.
Time: 9 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military
Road, NW., Washington, DC 20015.
Contact Person: Nadine Rogers, PhD, Scientific Review
Administrator, Office of Extramural Affairs, National Institute on
Drug Abuse, NIH, DHHS, Room 4229, MSC 9550, 6001 Executive Blvd.,
Bethesda, MD 20892-9550, 301-402-2105, [email protected].
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; Multi-site Clinical Trial.
Date: February 10, 2011.
Time: 1 p.m. to 3 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852 (Telephone Conference
Call).
Contact Person: Minna Liang, PhD, Scientific Review Officer,
Training and Special Projects Review Branch, Office of Extramural
Affairs, National Institute on Drug Abuse, NIH, Room 4226, MSC 9550,
6001 Executive Blvd., Bethesda, MD 20892-9550, 301-435-1432,
[email protected].
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; NIDA I/START R03 Small Grant Review.
Date: February 16, 2011.
Time: 9 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852 (Virtual Meeting).
Contact Person: Gerald L. McLaughlin, PhD, Scientific Review
Administrator, Office of Extramural Affairs, National Institute on
Drug Abuse, NIH, DHHS, Room 4238, MSC 9550, 6001 Executive Blvd.,
Bethesda, MD 20892-9550, 301-402-6626, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos.: 93.279, Drug
Abuse and Addiction Research Programs, National Institutes of
Health, HHS)
Dated: January 14, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2011-1251 Filed 1-20-11; 8:45 am]
BILLING CODE 4140-01-P